logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Keisuke Koroki

chiba university
H指数:14
被引数:614

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma

阿特珠单抗联合贝伐珠单抗可持久控制疾病，但进展后结局有限：一项多中心真实世界研究在晚期肝细胞癌中的应用

Cancer Medicine
IF3.1
2026-02-180
OAAI
Inoue, Masanori; Ogasawara, Sadahisa; Asahara, Kazuhisa; Sato, Rui; Watanabe, Shunji; Anzai, Haruka; Tsubura, Kazuo; Watabe, Taro; Fujiya, Makoto; Akatsuka, Teppei; Izai, Ryo; Katayama, Keiichi; Sawada, Midori; Tsuchiya, Takahiro; Miwa, Chihiro; Yoshino, Ryohei; Yonemoto, Takuya; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Kanzaki, Hiroaki; Koroki, Keisuke; Kobayashi, Kazufumi; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Yokoyama, Masayuki; Kato, Jun; Moriguchi, Michihisa; Aramaki, Takeshi; Morimoto, Naoki
MVI-targeted Carbon-ion Radiotherapy Combined with Immunotherapy for Advanced Hepatocellular Carcinoma: Phase Ib DEPARTURE Trial
JHEP Reports
IF7.5
2026-02-050
OAAI
Sadahisa Ogasawara; Keisuke Koroki; Hirokazu Makishima; Masaru Wakatsuki; Asahi Takahashi; Makoto Fujiya; Sae Yumita; Miyuki Nakagawa; Hiroaki Kanzaki; Kazufumi Kobayashi; Masanori Inoue; Masato Nakamura; Naoya Kanogawa; Takayuki Kondo; Shingo Nakamoto; Tomoya Kurokawa; Yoshihito Ozawa; Yosuke Inaba; Soumith Paritala; Jingxuan Chen
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma

系统性治疗后晚期肝细胞癌转归为碳离子放射治疗的探索性病例系列研究

International Cancer Conference Journal
IF0.5
2026-01-010
OA
Anzai, Haruka; Miwa, Chihiro; Ogasawara, Sadahisa; Fujiya, Makoto; Kurosaki, Hiroki; Tsuchiya, Takahiro; Yoshino, Ryohei; Katayama, Keiichi; Sawada, Midori; Akatsuka, Teppei; Izai, Ryo; Yonemoto, Takuya; Yumita, Sae; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Makishima, Hirokazu; Shinoto, Makoto; Wakatsuki, Masaru; Yamada, Shigeru; Ishikawa, Hitoshi; Kato, Jun
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes

阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的疗效与肿瘤浸润淋巴细胞的关系

JHEP Reports
IF7.5
2025-10-010
OAAI
Hiroaki Kanzaki; Takamasa Ishino; Sadahisa Ogasawara; Takahiro Tsuchiya; Makoto Fujiya; Midori Sawada; Ryo Izai; Teppei Akatsuka; Chihiro Miwa; Takuya Yonemoto; Sae Yumita; Miyuki Nakagawa; Ryuta Kojima; Keisuke Koroki; Masanori Inoue; Kazufumi Kobayashi; Naoya Kanogawa; Masato Nakamura; Takayuki Kondo; Shingo Nakamoto; Tsukasa Takayashiki; Yuka Takano; Kaho Takata; Jason Lin; Masahito Kawazu; Jun-ichiro Ikeda; Masayuki Ohtsuka; Yujin Hoshida; Mina Komuta; Yosuke Togashi
Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma

疾病复杂性及阿替利珠单抗联合贝伐珠单抗在晚期肝细胞癌中针对结节的具体反应

LIVER CANCER
IF9.1
2025-09-010
PRE
Yumita, Sae; Ogasawara, Sadahisa; Fujiya, Makoto; Akatsuka, Teppei; Izai, Ryo; Katayama, Keiichi; Sawada, Midori; Tsuchiya, Takahiro; Miwa, Chihiro; Yoshino, Ryohei; Yonemoto, Takuya; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Nagashima, Kengo; Kato, Jun
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma

随机对照II期研究，比较regorafenib两种剂量在晚期肝细胞癌二线治疗中的应用。

JHEP Reports
IF7.5
2025-07-110
OAAI
Keisuke Koroki; Sadahisa Ogasawara; Sae Yumita; Miyuki Nakagawa; Hiroaki Kanzaki; Kazufumi Kobayashi; Masanori Inoue; Masato Nakamura; Naoya Kanogawa; Takayuki Kondo; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Yuki Shiko; Yoshihito Ozawa; Yosuke Inaba
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
BIOCHEMICAL PHARMACOLOGY
IF5.6
2025-02-010
PRE
Qiang, Na; Ao, Junjie; Nakamura, Masato; Katayama, Keichi; Zhang, Jiaqi; Kogure, Tadayoshi; Ogawa, Keita; Kanzaki, Hiroaki; Kojima, Ryuta; Koroki, Keisuke; Kobayashi, Kazufumi; Inoue, Masanori; Kanogawa, Naoya; Kiyono, Soichiro; Nakagawa, Ryo; Kondo, Takayuki; Ogasawara, Sadahisa; Nakamoto, Shingo; Muroyama, Ryosuke; Kato, Jun; Kato, Naoya
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma

评估免疫检查点抑制剂的两种再攻击策略: Durvalumab联合tremelimumab治疗晚期肝细胞癌

HEPATOLOGY RESEARCH
IF3.4
2025-01-150
OA
Yonemoto, Takuya; Ogasawara, Sadahisa; Kanogawa, Naoya; Miwa, Chihiro; Fujiya, Makoto; Tsuchiya, Takahiro; Sawada, Midori; Akatsuka, Teppei; Izai, Ryo; Yumita, Sae; Nakagawa, Miyuki; Okubo, Tomomi; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Itokawa, Norio; Atsukawa, Masanori; Itobayashi, Ei; Moriguchi, Michihisa; Kato, Naoya
Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma
LIVER CANCER
IF9.1
2024-11-130
OAAI
Koroki, Keisuke; Ogasawara, Sadahisa; Izai, Ryo; Yonemoto, Takuya; Akatsuka, Teppei; Miwa, Chihiro; Yumita, Sae; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nakada, Shinichiro; Sakai, Nozomu; Yokoyama, Masayuki; Ohtsuka, Masayuki; Kato, Naoya
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis
HEPATOLOGY RESEARCH
IF3.4
2024-06-291
PRE
Ozaki, Tomomi; Yumita, Sae; Ogasawara, Sadahisa; Fujiya, Makoto; Tsuchiya, Takahiro; Yoshino, Ryohei; Sawada, Midori; Akatsuka, Teppei; Izai, Ryo; Miwa, Chihiro; Yonemoto, Takuya; Fujimoto, Kentaro; Unozawa, Hidemi; Fujiwara, Kisako; Kojima, Ryuta; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Nakamura, Masato; Kiyono, Soichiro; Kanogawa, Naoya; Kondo, Takayuki; Nakagawa, Ryo; Nakamoto, Shingo; Kato, Naoya
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)
INVESTIGATIONAL NEW DRUGS
IF2.7
2024-06-060
OAAI
Kobayashi, Kazufumi; Ogasawara, Sadahisa; Itobayashi, Ei; Okubo, Tomomi; Itokawa, Norio; Nakamura, Kazuyoshi; Moriguchi, Michihisa; Watanabe, Shunji; Ikeda, Masafumi; Kuroda, Hidekatsu; Kawaoka, Tomokazu; Hiraoka, Atsushi; Yasui, Yutaka; Kuzuya, Teiji; Sato, Rui; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kiyono, Soichiro; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Ozawa, Yoshihito; Tsuchiya, Kaoru; Atsukawa, Masanori; Aikata, Hiroshi; Aramaki, Takeshi; Oka, Shiro; Morimoto, Naoki; Kurosaki, Masayuki; Itoh, Yoshito; Izumi, Namiki; Kato, Naoya
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
LIVER CANCER
IF9.1
2024-05-210
OAAI
Inoue, Masanori; Ogasawara, Sadahisa; Kobayashi, Kazufumi; Okubo, Tomomi; Itokawa, Norio; Obu, Masamichi; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Fujiwara, Kisako; Nakagawa, Miyuki; Kanzaki, Hiroaki; Koroki, Keisuke; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nagashima, Kengo; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Kato, Naoya
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma
JOURNAL OF GASTROENTEROLOGY
IF5.5
2024-04-071
OAAI
Fujiwara, Kisako; Kondo, Takayuki; Fujimoto, Kentaro; Yumita, Sae; Ogawa, Keita; Ishino, Takamasa; Nakagawa, Miyuki; Iwanaga, Terunao; Tsuchiya, Satoshi; Koroki, Keisuke; Kanzaki, Hiroaki; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Ogasawara, Sadahisa; Nakamoto, Shingo; Chiba, Tetsuhiro; Koizumi, Jun; Kato, Jun; Kato, Naoya
Exploring the efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Kanzaki, Hiroaki; Ishino, Takamasa; Ogasawara, Sadahisa; Yumita, Sae; Nakagawa, Miyuki; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Kiyono, Soichiro; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Takayashiki, Tsukasa; Lin, Jason; Kawazu, Masahito; Komuta, Mina; Ikeda, Jun-ichiro; Ohtsuka, Masayuki; Togashi, Yosuke; Kato, Naoya
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
SCIENTIFIC REPORTS
IF3.9
2023-08-282
OAAI
Kondo, Takayuki; Fujimoto, Kentaro; Fujiwara, Kisako; Yumita, Sae; Ishino, Takamasa; Ogawa, Keita; Nakagawa, Miyuki; Iwanaga, Terunao; Koroki, Keisuke; Kanzaki, Hiroaki; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Ogasawara, Sadahisa; Nakamoto, Shingo; Chiba, Tetsuhiro; Kato, Jun; Fujiwara, Keiichi; Kato, Naoya
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients
SCIENTIFIC REPORTS
IF3.9
2023-07-172
OAAI
Kondo, Takayuki; Fujiwara, Kisako; Nakagawa, Miyuki; Fujimoto, Kentaro; Yumita, Sae; Ishino, Takamasa; Ogawa, Keita; Iwanaga, Terunao; Koroki, Keisuke; Kanzaki, Hiroaki; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Ogasawara, Sadahisa; Nakamoto, Shingo; Chiba, Tetsuhiro; Kato, Jun; Kato, Naoya
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
SCIENTIFIC REPORTS
IF3.9
2022-12-011
OAAI
Kondo, Takayuki; Fujiwara, Kisako; Nakagawa, Miyuki; Unozawa, Hidemi; Iwanaga, Terunao; Sakuma, Takafumi; Fujita, Naoto; Koroki, Keisuke; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Saito, Tomoko; Ogasawara, Sadahisa; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Chiba, Tetsuhiro; Arai, Makoto; Kato, Jun; Kato, Naoya

研究方向

暂未获取到该数据
S
Sadahisa Ogasawara
H 指数:38论文数:340被引数:1.2万
N
Naoya Kanogawa
H 指数:21论文数:157被引数:1,494
K
Kazufumi Kobayashi
H 指数:20论文数:150被引数:1,205
H
Hiroaki Kanzaki
H 指数:19论文数:142被引数:1,040
M
Masato Nakamura
H 指数:52论文数:684被引数:1.1万
N
Naoya Kato
H 指数:61论文数:622被引数:1.4万
S
Soichiro Kiyono
H 指数:19论文数:161被引数:1,114
S
Shingo Nakamoto
H 指数:30论文数:231被引数:2,725
T
Takayuki Kondo
H 指数:20论文数:151被引数:1,218
T
Tetsuhiro Chiba
H 指数:47论文数:357被引数:7,335